By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Johannes Vermeerplain 9-1

Amsterdam      The Netherlands
Phone: 31-20-6645500 Fax: n/a



Company News
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014 9:23:21 AM
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014 6:00:06 AM
QIAGEN N.V. (QGEN) Adds Promising Genomic Biomarkers For Assessing Prognosis In Treatment Of Blood Cancers To Personalized Healthcare Pipeline 7/25/2014 7:35:26 AM
QIAGEN N.V. (QGEN) Advances Leadership In Pre-Analytical Solutions For Next-Generation Sequencing (NGS) With Launch Of 14 New Cancer Gene Panels 7/16/2014 8:49:50 AM
QIAGEN N.V. (QGEN) And Eli Lilly and Company (LLY) Collaborate To Co-Develop Companion Diagnostics For Simultaneous Analysis Of Dna And Rna Biomarkers In Common Cancers 5/30/2014 10:23:35 AM
QIAGEN N.V. (QGEN) Wins FDA Approval Of therascreen® KRAS RGQ PCR Kit Paired With Second Colorectal Cancer Drug 5/27/2014 6:28:12 AM
QIAGEN N.V. (QGEN) Posts 2013 Annual Report On Its Website 4/24/2014 9:07:43 AM
QIAGEN N.V. (QGEN) To Report First Quarter 2014 Results And Hold Webcast 4/9/2014 8:25:58 AM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C Represents QIAGEN N.V. (QGEN) In Major Convertible Note Offering 4/7/2014 9:50:02 AM
QIAGEN N.V. (QGEN) Announces New Offering To Address Workflow Challenges Of NGS And Improved Bioinformatics 4/3/2014 12:30:09 PM